Form 4: AbCellera Biologics Director Buys Shares
Insider Transaction (Form 4)
John S. Montalbano, a Director of AbCellera Biologics Inc., purchased 10,000 shares of common stock on August 18, 2026 for $11.03 per share.
Summary
- Open-market purchase: acquired 10,000 Common Shares at $11.03 ($110,300) on August 18, 2026; holds 251,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $110,300, committing personal capital to the stock.
Insider Transactions
John S. Montalbano — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market purchase | Common Shares | 10,000 | $11 | $110.3K | 251,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market purchase (10,000 shares) |
Keywords
insider transaction, Form 4, ABCL, AbCellera Biologics Inc., bullish, John S. Montalbano
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.